Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Zimbabwe bans foreign currency

Jun 25, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Tech
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Commentary

Can big fraud settlements curb corporate misdeeds?

Marketplace Contributor Jul 11, 2012
Share Now on:
HTML EMBED:
COPY

The charges were deadly serious. Among other things, Glaxo was alleged to have promoted to kids under 18 an antidepressant approved only for adults and for pushing two other anti-depressants for unapproved purposes, including treatment of sexual dysfunction. To further boost sales, the company is said to have showered doctors with gifts, consulting contracts, speaking fees, even tickets to sporting events.

Now $3 billion may sound like a lot of money, but during the years covered under the settlement, Glaxo is reported to have made nearly $30 billion on these three anti-depressants alone.

But to the extent the penalty will affect Glaxo’s profits and share price, the wrong people will be feeling the financial pain. Most of today’s Glaxo shareholders bought into the company after the ill-gotten profits were already built into the price they paid for their shares.

The only way to get a big company like this to change its ways is by making individual executives feel the heat. But not a single executive has been charged. Glaxo has agreed to reclaim the bonuses of any executives who engaged in or supervised improper behavior. But without legal charges against the executives involved, it’s impossible to know whether Glaxo will follow through.

An even more basic issue is why the advertising and marketing of prescription drugs is allowed at all, when consumers can’t buy them and shouldn’t be influencing doctors’ decisions anyway. Before 1997, the Food and Drug Administration banned such advertising on TV and radio. That ban should be resurrected.

Finally, there’s no good reason why doctors should be allowed to accept any perks at all from companies whose drugs they write prescriptions for. Codes of ethics that are supposed to limit such gifts obviously don’t work. All perks should be banned, and doctors that accept them should be subject to potential loss of their license to practice. It’s an inherent conflict of interest.

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.